Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis. uri icon

authors

  • Salhotra, Amandeep
  • Ali, Haris
  • Aldoss, Ibrahim
  • Otoukesh, Salman
  • Arslan, Shukaib
  • Ball, Brian
  • Koller, Paul
  • Amanam, Idoroenyi
  • Pourhassan, Hoda
  • Blackmon, Amanda
  • Becker, Pamela
  • Yang, Dongyun
  • Pullarkat, Vinod
  • Andrew Artz, MD, MS
  • Smith, Eileen
  • Marcucci, Guido
  • Forman, Stephen
  • Stein, Anthony
  • Nakamura, Ryotaro
  • Al Malki, Monzr M
  • Mokhtari, Sally
  • Knobler, Diana
  • Agarwal, Vaibhav
  • Sandhu, Karamjeet
  • Park, Gabriel
  • Aribi, Ahmed

publication date

  • November 18, 2025